Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens
Clinical trial NCT01502085 · COMPLETED
Trial details
- NCT number
- NCT01502085
- Sponsor
- Hackensack Meridian Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.